These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14666683)

  • 1. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
    Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
    Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein e expression in anaplastic thyroid carcinoma.
    Ito Y; Takano T; Miyauchi A
    Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of S100A2 and S100A6 in thyroid carcinomas.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.
    Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(1B):569-76. PubMed ID: 12680148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J
    Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.
    Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
    Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
    Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
    Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
    Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.
    Diaz NM; Mazoujian G; Wick MR
    Arch Pathol Lab Med; 1991 Dec; 115(12):1203-7. PubMed ID: 1768209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tie-1 tyrosine kinase expression in human thyroid neoplasms.
    Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Histopathology; 2004 Apr; 44(4):318-22. PubMed ID: 15049896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.